These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4267735)

  • 21. [Determination of FDP by staphylococcal clumping test and the significance of the method in consumption coagulopathy].
    Yamada K; Yamada Z; Nakazawa S; Matsuoka S
    Rinsho Ketsueki; 1972 Jun; 13(3):411-4. PubMed ID: 4674971
    [No Abstract]   [Full Text] [Related]  

  • 22. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation products.
    Soria J; Soria C; Bertrand O; Dunn F; Samama M; Bachmann F
    Thromb Haemost; 1982 Jun; 47(3):193-6. PubMed ID: 7051407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physiopathology of consumption coagulopathies].
    Cuocolo R; Ortolani O; Conti A
    Minerva Anestesiol; 1980 Jul; 46(7):827-42. PubMed ID: 7017463
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Consumption coagulopathies in childhood].
    Heinrichs C; Steinitz L
    Z Arztl Fortbild (Jena); 1972 Sep; 66(17):853-9. PubMed ID: 4264282
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
    Loly W; Israels LG; Bishop AJ; Israels ED
    Thromb Diath Haemorrh; 1971 Dec; 26(3):526-40. PubMed ID: 4259443
    [No Abstract]   [Full Text] [Related]  

  • 29. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 30. [Efficiency and limits of laboratory diagnosis of diffuse intravascular blood coagulation processes].
    Heene DL; Lasch HG
    Internist (Berl); 1973 Apr; 14(4):154-9. PubMed ID: 4268495
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen breakdown products: identification and assay in serum and urine.
    Rayner H; Parashevas F; Israels LG; Israels ED
    J Lab Clin Med; 1969 Oct; 74(4):586-96. PubMed ID: 4241717
    [No Abstract]   [Full Text] [Related]  

  • 32. What role does the measurement of fibrinogen and its derivatives have in the diagnosis of disseminated intravascular coagulation?
    Dempfle CE
    Blood Rev; 2002 Dec; 16 Suppl 1():S23-8. PubMed ID: 12918784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemagglutination inhibition (Merskey's test) in consumption coagulopathies. Apropos of 101 patients].
    Soria J; Soria C; Yver J; Girard ML; Samama M; Bilski-Pasquier G
    Presse Med (1893); 1971 May; 79(22):1003-6. PubMed ID: 5281042
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinogen degradation products.
    Sack ES; Buraschi J
    N Engl J Med; 1971 Jun; 284(25):1441. PubMed ID: 5578330
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of a polyacrylamide gel gradient for the separation of fibrinogen degradation products. Sensitivity of the immunological reaction of hemagglutination inhibition. Merskey's test on various isolated fragments].
    Soria J; Fabiani P
    Ann Biol Clin (Paris); 1971; 29(4):303-7. PubMed ID: 4257050
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrinogen degradation products: a critical study of two assay methods.
    Thuot C; Larrieu MJ
    Rev Eur Etud Clin Biol; 1971; 16(1):27-34. PubMed ID: 4252113
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.